Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-06-03
2010-06-01
Shukla, Ram R (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388220
Reexamination Certificate
active
07728114
ABSTRACT:
The present invention is related to antibodies directed to the antigen CD3 and uses of such antibodies. In particular, the present invention provides fully human monoclonal antibodies directed to CD3. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
REFERENCES:
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5624821 (1997-04-01), Winter et al.
patent: 5648260 (1997-07-01), Winter et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693792 (1997-12-01), Torii et al.
patent: 5714350 (1998-02-01), Co et al.
patent: 5777085 (1998-07-01), Co et al.
patent: 5834597 (1998-11-01), Tso et al.
patent: 5859205 (1999-01-01), Adair et al.
patent: 5885573 (1999-03-01), Bluestone et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6113901 (2000-09-01), Bluestone
patent: 6143297 (2000-11-01), Bluestone
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6406696 (2002-06-01), Bluestone
patent: 6491916 (2002-12-01), Bluestone et al.
patent: 6521404 (2003-02-01), Griffiths et al.
patent: 7041289 (2006-05-01), Bach et al.
patent: 2003/0108548 (2003-06-01), Bluestone et al.
patent: 2003/0216551 (2003-11-01), Delovitch
patent: 2003/0235583 (2003-12-01), Sturis et al.
patent: 2004/0037826 (2004-02-01), Michelsen et al.
patent: 2006/0002933 (2006-01-01), Blueston et al.
patent: 2006/0165691 (2006-07-01), Bolt et al.
patent: 2006/0165692 (2006-07-01), Bolt et al.
patent: 2006/0165693 (2006-07-01), Bolt et al.
patent: 2006/0275292 (2006-12-01), Delovitch
patent: 2006/0292142 (2006-12-01), Bluestone et al.
patent: 2007/0077246 (2007-04-01), Koenig et al.
patent: 2007/0178092 (2007-08-01), Bolt et al.
patent: 2007/0190045 (2007-08-01), Herold et al.
patent: 2007/0190052 (2007-08-01), Herold et al.
patent: 2007/0224191 (2007-09-01), Walters et al.
patent: 2008/0095766 (2008-04-01), Koenig et al.
patent: 2179862 (2002-02-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 94/28027 (1994-12-01), None
patent: WO 97/44362 (1997-11-01), None
patent: WO 03/026692 (2003-04-01), None
patent: WO 2004/052397 (2004-06-01), None
patent: WO 2004/106380 (2004-12-01), None
patent: WO 2005/048935 (2005-06-01), None
patent: WO 2007/117600 (2007-10-01), None
patent: WO 2007/145941 (2007-12-01), None
patent: WO 2007/147090 (2007-12-01), None
patent: WO 2008/079713 (2008-07-01), None
patent: WO 2008/119567 (2008-10-01), None
Eduardo Padlan, Mol Immunol. Feb. 1994;31(3):169-217.
Portolano et al., J Immunol. Feb. 1, 1993;150(3):880-7.
Gonzalez et al., Mol Immunol. Jul. 2004;41(9):863-72.
Bose et al., Immunology, 2005. 116:172-183.
Morgan et al., J Exp Med. Mar. 1, 1983; 157(3): 947-956.
Adair et al.Hum. Antibod. Hybridomas, 5(1-2):41-47 (1994).
Chothia et al.J. Mol. Biol., 196(4):901-917 (1987).
Chothia et al.Nature, 342:877-883 (1989).
Frank et al.Meth. Mol. Biol., Chapter 15, 66:149-169 (1996).
Geysen et al.J. Immunol. Meth., 102(2):259-274 (1987).
Green et al.Nat. Gen., 7:13-21 (1994).
Hayward et al.Immunol., 64(1):87-92 (1988).
Ledbetter et al.J. Immunol., 136(11):3945-3952 (1986).
Kramer et al.Meth. Mol. Biol., Chapter 4, 87:25-39 (1998).
Kung et al.Science, 206:347-349 (1979).
Kung et al.Transplant. Proc., XII(3 -Suppl. 1):141-146 (1980).
Kung et al.Int. J. Immunopharmacol., 3(3):175-181 (1981).
Liu et al.J. Immunol., 139(10):3521-3526 (1987).
Liu et al.Proc. Natl. Acad. Sci. USA, 84:3439-3443 (1987).
Renders et al.Clin. Exp. Immunol., 133(3):307-309 (2003).
Winter et al.Immunol. Today, 14(6):243-246 (1993).
Wright et al.Crit. Rev. Immunol., vol. 12(3,4):125-168 (1992).
Xu et al.Cell. Immunol., 200(1):16-26 (2000).
Yang et al.J. Immunol., 137(4):1097-1100 (1986).
International Search Report for PCT/US2005/019922, mailed May 3, 2006.
Dean Yann
Elson Greg
Fischer Nicolas
Kosco-Vilbois Marie
Leger Olivier
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Novimmune S.A.
Shukla Ram R
Skelding Zachary
LandOfFree
Anti-CD3 antibodies and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CD3 antibodies and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CD3 antibodies and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4159692